<?xml version='1.0' encoding='utf-8'?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2011//EN" "http://www.ncbi.nlm.nih.gov/entrez/query/DTD/pubmed_110101.dtd">
<pubmedarticleset>
 <pubmedarticle>
  <medlinecitation owner="NLM" status="MEDLINE">
   <pmid version="1">
    14586043
   </pmid>
   <datecreated>
    <year>
     2003
    </year>
    <month>
     10
    </month>
    <day>
     30
    </day>
   </datecreated>
   <datecompleted>
    <year>
     2003
    </year>
    <month>
     11
    </month>
    <day>
     25
    </day>
   </datecompleted>
   <daterevised>
    <year>
     2009
    </year>
    <month>
     11
    </month>
    <day>
     18
    </day>
   </daterevised>
   <article pubmodel="Print">
    <journal>
     <issn issntype="Print">
      0040-6376
     </issn>
     <journalissue citedmedium="Print">
      <volume>
       58
      </volume>
      <issue>
       11
      </issue>
      <pubdate>
       <year>
        2003
       </year>
       <month>
        Nov
       </month>
      </pubdate>
     </journalissue>
     <title>
      Thorax
     </title>
     <isoabbreviation>
      Thorax
     </isoabbreviation>
    </journal>
    <articletitle>
     Inhaled corticosteroids reduce the progression of airflow limitation in chronic obstructive pulmonary disease: a meta-analysis.
    </articletitle>
    <pagination>
     <medlinepgn>
      937-41
     </medlinepgn>
    </pagination>
    <abstract>
     <abstracttext label="BACKGROUND" nlmcategory="BACKGROUND">
      Chronic obstructive pulmonary disease (COPD) is a syndrome of chronic progressive airflow limitation which occurs as a result of chronic inflammation of the airways and lung parenchyma. However, the role of inhaled corticosteroids in the treatment of COPD is controversial. We hypothesised that inhaled corticosteroids reduce the progression of airflow limitation in COPD.
     </abstracttext>
     <abstracttext label="METHODS" nlmcategory="METHODS">
      A comprehensive literature search was conducted and data were analysed using random effects methodology. The effect of inhaled steroids on annual change in forced expiratory volume in 1 second (FEV1) was determined for all trials, for trials with high dose treatment regimens, and for trials in subjects with moderate to severe airflow limitation.
     </abstracttext>
     <abstracttext label="RESULTS" nlmcategory="RESULTS">
      Data from eight controlled clinical trials of &gt; or =2 years were included (n=3715 subjects). Meta-analysis of all study data revealed that inhaled corticosteroids reduce the rate of FEV1 decline by 7.7 ml/year (95% confidence interval (CI) 1.3 to 14.2, p=0.02). Meta-analysis of studies with high dose regimens revealed a greater effect of 9.9 ml/year (95% CI 2.3 to 17.5, p=0.01) compared with the meta-analysis of all studies.
     </abstracttext>
     <abstracttext label="CONCLUSIONS" nlmcategory="CONCLUSIONS">
      Inhaled corticosteroid treatment for &gt; or =2 years slows the rate of lung function decline in COPD. The effect observed with high dose regimens is greater than that with all regimens combined. These data suggest a potential role for inhaled corticosteroids in modifying the long term natural history of COPD.
     </abstracttext>
    </abstract>
    <affiliation>
     Department of Medicine, National Jewish Medical and Research Center and the University of Colorado Health Sciences Center, Denver, Colorado, USA. sutherlande@njc.org
    </affiliation>
    <authorlist completeyn="Y">
     <author validyn="Y">
      <lastname>
       Sutherland
      </lastname>
      <forename>
       E R
      </forename>
      <initials>
       ER
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Allmers
      </lastname>
      <forename>
       H
      </forename>
      <initials>
       H
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Ayas
      </lastname>
      <forename>
       N T
      </forename>
      <initials>
       NT
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Venn
      </lastname>
      <forename>
       A J
      </forename>
      <initials>
       AJ
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Martin
      </lastname>
      <forename>
       R J
      </forename>
      <initials>
       RJ
      </initials>
     </author>
    </authorlist>
    <language>
     eng
    </language>
    <grantlist completeyn="Y">
     <grant>
      <grantid>
       K23 HL04385
      </grantid>
      <acronym>
       HL
      </acronym>
      <agency>
       NHLBI NIH HHS
      </agency>
      <country>
       United States
      </country>
     </grant>
    </grantlist>
    <publicationtypelist>
     <publicationtype>
      Journal Article
     </publicationtype>
     <publicationtype>
      Meta-Analysis
     </publicationtype>
     <publicationtype>
      Research Support, Non-U.S. Gov't
     </publicationtype>
     <publicationtype>
      Research Support, U.S. Gov't, P.H.S.
     </publicationtype>
    </publicationtypelist>
   </article>
   <medlinejournalinfo>
    <country>
     England
    </country>
    <medlineta>
     Thorax
    </medlineta>
    <nlmuniqueid>
     0417353
    </nlmuniqueid>
    <issnlinking>
     0040-6376
    </issnlinking>
   </medlinejournalinfo>
   <chemicallist>
    <chemical>
     <registrynumber>
      0
     </registrynumber>
     <nameofsubstance>
      Adrenal Cortex Hormones
     </nameofsubstance>
    </chemical>
   </chemicallist>
   <citationsubset>
    IM
   </citationsubset>
   <commentscorrectionslist>
    <commentscorrections reftype="Cites">
     <refsource>
      Am J Respir Crit Care Med. 2001 Apr;163(5):1256-76
     </refsource>
     <pmid version="1">
      11316667
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Am J Respir Crit Care Med. 2001 Jan;163(1):122-8
     </refsource>
     <pmid version="1">
      11208636
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Am J Med. 2002 Jul;113(1):59-65
     </refsource>
     <pmid version="1">
      12106623
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Am J Respir Crit Care Med. 2002 Sep 1;166(5):675-9
     </refsource>
     <pmid version="1">
      12204864
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Thorax. 2002 Oct;57(10):847-52
     </refsource>
     <pmid version="1">
      12324669
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      N Engl J Med. 1992 Nov 12;327(20):1413-9
     </refsource>
     <pmid version="1">
      1357553
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Epidemiol Rev. 1987;9:1-30
     </refsource>
     <pmid version="1">
      3678409
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Control Clin Trials. 1986 Sep;7(3):177-88
     </refsource>
     <pmid version="1">
      3802833
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Biometrics. 1994 Dec;50(4):1088-101
     </refsource>
     <pmid version="1">
      7786990
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Chest. 1996 May;109(5):1156-62
     </refsource>
     <pmid version="1">
      8625660
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Ann Pharmacother. 1997 Feb;31(2):160-4
     </refsource>
     <pmid version="1">
      9034414
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      BMJ. 1997 Sep 13;315(7109):629-34
     </refsource>
     <pmid version="1">
      9310563
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Thorax. 2002 Jun;57(6):528-32
     </refsource>
     <pmid version="1">
      12037229
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      N Engl J Med. 2000 Jul 27;343(4):269-80
     </refsource>
     <pmid version="1">
      10911010
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      BMJ. 2000 May 13;320(7245):1297-303
     </refsource>
     <pmid version="1">
      10807619
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Am J Respir Crit Care Med. 1999 Nov;160(5 Pt 1):1635-9
     </refsource>
     <pmid version="1">
      10556133
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Thorax. 1999 Jan;54(1):7-14
     </refsource>
     <pmid version="1">
      10343624
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Lancet. 1999 May 29;353(9167):1819-23
     </refsource>
     <pmid version="1">
      10359405
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      N Engl J Med. 1999 Jun 24;340(25):1948-53
     </refsource>
     <pmid version="1">
      10379018
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Clin Exp Allergy. 1999 Jun;29 Suppl 2:125-8
     </refsource>
     <pmid version="1">
      10421835
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="CommentIn">
     <refsource>
      ACP J Club. 2004 May-Jun;140(3):57
     </refsource>
     <pmid version="1">
      15122820
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="CommentIn">
     <refsource>
      Thorax. 2004 Jun;59(6):539; author reply 539-40
     </refsource>
     <pmid version="1">
      15170046
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="CommentIn">
     <refsource>
      Thorax. 2004 Jun;59(6):538-9; author reply 539-40
     </refsource>
     <pmid version="1">
      15170045
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="CommentIn">
     <refsource>
      Thorax. 2003 Nov;58(11):911-3
     </refsource>
     <pmid version="1">
      14586036
     </pmid>
    </commentscorrections>
   </commentscorrectionslist>
   <meshheadinglist>
    <meshheading>
     <descriptorname majortopicyn="N">
      Administration, Inhalation
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Adrenal Cortex Hormones
     </descriptorname>
     <qualifiername majortopicyn="Y">
      administration &amp; dosage
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Dose-Response Relationship, Drug
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Forced Expiratory Volume
     </descriptorname>
     <qualifiername majortopicyn="N">
      drug effects
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Humans
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Pulmonary Disease, Chronic Obstructive
     </descriptorname>
     <qualifiername majortopicyn="Y">
      drug therapy
     </qualifiername>
     <qualifiername majortopicyn="N">
      physiopathology
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Treatment Outcome
     </descriptorname>
    </meshheading>
   </meshheadinglist>
   <otherid source="NLM">
    PMC1746510
   </otherid>
  </medlinecitation>
  <pubmeddata>
   <history>
    <pubmedpubdate pubstatus="pubmed">
     <year>
      2003
     </year>
     <month>
      10
     </month>
     <day>
      31
     </day>
     <hour>
      5
     </hour>
     <minute>
      0
     </minute>
    </pubmedpubdate>
    <pubmedpubdate pubstatus="medline">
     <year>
      2003
     </year>
     <month>
      12
     </month>
     <day>
      3
     </day>
     <hour>
      5
     </hour>
     <minute>
      0
     </minute>
    </pubmedpubdate>
    <pubmedpubdate pubstatus="entrez">
     <year>
      2003
     </year>
     <month>
      10
     </month>
     <day>
      31
     </day>
     <hour>
      5
     </hour>
     <minute>
      0
     </minute>
    </pubmedpubdate>
   </history>
   <publicationstatus>
    ppublish
   </publicationstatus>
   <articleidlist>
    <articleid idtype="pubmed">
     14586043
    </articleid>
    <articleid idtype="pmc">
     PMC1746510
    </articleid>
   </articleidlist>
  </pubmeddata>
 </pubmedarticle>
</pubmedarticleset>

